頁籤選單縮合
題名 | Efficient Cost Containment Strategies for Pharmaceutical Expenditure= |
---|---|
作者 | 許茜甯; Hsu, Chien-ning; |
期刊 | 藥學雜誌 |
出版日期 | 20101200 |
卷期 | 26:4=105 2010.12[民99.12] |
頁次 | 頁9-16 |
分類號 | 419.45 |
語文 | eng |
關鍵詞 | Cost-containment strategy; Pharmaceutical expenditure; Restriction on drug utilization; Pricing policy; Health technology assessment; HTA; |
中文摘要 | 藥物費用支出一直成長得比其他醫療項目支出來得快,已造成政府及醫療系統中相關人士相當負荷及憂心。台灣在全民健康保險制度下,藥物費用支出從 1997年64億新台幣已增加到 2008年125.1億新台幣,且每年一直占總醫療支出大約 25%。面對不斷成長的費用壓力,其策略不外是補足財務上不足或是限制該項費用支出;亦或是二者同步進行才能有效控制費用成長。由於挪用其他公共支出、增加健康保險費率或增加病患部分負擔各有其不同層次的困難度,通常各種能控制費用支出的作法或策略較易被廣為引用。 本文呈現文獻上提及幾項常被引用來控制費用支出的作法、討論控制費用策略可能衍生的利與弊、並提出其他可能的作法不僅長期可以達到控制費用支出,並可增進每一筆藥費支出的價值。 |
英文摘要 | Pharmaceutical expenditures have been increasing much faster than spending on other medical services and have become burdensome for policy makers and stakeholders in the medical society worldwide. From 1997 to 2008, overall national spending on pharmaceuticals in Taiwan increased from 64.0 to 125.1 billion Taiwan dollars (NT$); and remained approximately 25% of total national health expenditure. As a consequence of that development, that additional expenditure must either be financed or it must in one way or another be constrained; both approaches will probably have to be adopted in parallel. Because either increasing public spending or increasing patient sharing may meet with different level of difficulties, cost control has attracted considerable public attentions. This paper presents cost-containment strategies that have been adopted by the policy makers and health providers who are responsible for formulary management with the promise of cost saving; and discuss some other thoughts that might be attributable to cost saving and improve the value of pharmaceutical expenditure in the long-run. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。